北京地区36家医院2002～2005年肝素类药物利用分析

Consumption of Heparins in 36 Hospitals of Beijing in 2002～2005

目的:评价北京地区医院肝素类药物的应用现状及发展趋势。方法:对北京地区36家医院2002-2005年肝素及低分子肝素7个品种22个规格药品的用药频度(DDDs)、日均费用、销售金额等进行统计、分析。结果:4年中肝素钠DDDs始终排第1位,规格为4 000IU～6 000IU的低分子肝素DDDs排序4年中占前10位的60％;DDDs／销售金额排序(B／A)值在0．9～1．1之间的分别为当年的50．00％、50．00％、54．55％、63．64％;销售金额列前5位的均为低分子肝素。结论:肝素类药物的市场前景广阔。

OBJECTIVE： To evaluate the current use and development trend of heparins in Beijing .METHODS： Consumption of heparins used in 2002-2005 in 36 hospitals of Beijing was audited and analyzed through rankings of sales value, DDDs and DDC, covering 7 heparin ＆ low molecular heparin agents in 22 specifications.RESULTS： Heparin Sodium placed itself first in DDDs for all of the four years, followed by low molecular heparin（4 000IU-6 000IU） .Agents with B/A value （DDDs/sales value ranking） ranging 0.9-1.1 represented 50.00 %, 50.00 %, 54.55 % and 63.64 % respectively of total sales for the four years.The top 5 sellers were all low molecular heparins .CONCLUSION： Heparins show great market potentials in Chinese hospitals.